Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 11/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | NAAA | Q02083 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8110938 | 0.92 | NAAA (0.42) | EPHX1ACHEALDH1A1SMN1; SMN2GAA | |
| SCHEMBL26679449 | 0.82 | GAA (0.46) | ALDH1A1GAARAB9A | |
| SCHEMBL526157 | 0.80 | ALDH1A1 (0.52) | ALDH1A1SMN1; SMN2ATMNAAA | |
| SCHEMBL813357 | 0.80 | ALDH1A1 (0.52) | ALDH1A1SMN1; SMN2ATMNAAA | |
| SCHEMBL552606 | 0.80 | ALDH1A1 (0.52) | ALDH1A1SMN1; SMN2ATMNAAA | |
| SCHEMBL812979 | 0.80 | ALDH1A1 (0.52) | ALDH1A1SMN1; SMN2ATMNAAA | |
| SCHEMBL3664894 | 0.79 | NAAA (0.52) | EPHX1ACHEALDH1A1SMN1; SMN2NPC1 | |
| SCHEMBL7065176 | 0.78 | PRCP (0.47) | EPHX1ACHESMN1; SMN2GAAMAPK1 | |
| SCHEMBL1297740 | 0.77 | ALDH1A1 (0.45) | EPHX1ACHEALDH1A1GAAATM | |
| SCHEMBL1297753 | 0.77 | NAAA (0.53) | EPHX1ALDH1A1SMN1; SMN2GAAMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1844022-A1 | QUINAZOLINE DERIVATIVES FOR INHIBITING CANCER CELL GROWTH AND METHOD FOR THE PREPARATION THEREOF | Hanmi Pharm. Co., Ltd. (KR) | 2007-10-17 | — | — | EP | disclosed |
| WO-2006071017-A1 | QUINAZOLINE DERIVATIVES FOR INHIBITING CANCER CELL GROWTH AND METHOD FOR THE PREPARATION THEREOF | HANMI PHARM. CO., LTD. (KR) | 2006-07-06 | — | — | WO | disclosed |
| EP-1061936-A4 | CYCLIC DIPEPTIDES AND AZETIDINONE COMPOUNDS AND THEIR USE IN TREATING CNS INJURY AND NEURODEGENERATIVE DISORDERS | UNIV GEORGETOWN (US) | 2005-03-09 | — | — | EP | disclosed |
| WO-2002034283-A2 | VEGH INHIBITORS AND THEIR USE | NOVARTIS AG (CH) | 2002-05-02 | — | — | WO | disclosed |
| EP-1061936-A1 | CYCLIC DIPEPTIDES AND AZETIDINONE COMPOUNDS AND THEIR USE IN TREATING CNS INJURY AND NEURODEGENERATIVE DISORDERS | GEORGETOWN UNIVERSITY (US) | 2000-12-27 | — | — | EP | disclosed |
| WO-1999040931-A1 | CYCLIC DIPEPTIDES AND AZETIDINONE COMPOUNDS AND THEIR USE IN TREATING CNS INJURY AND NEURODEGENERATIVE DISORDERS | GEORGETOWN UNIVERSITY (US) | 1999-08-19 | — | — | WO | disclosed |